{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:49:15Z","timestamp":1783075755932,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>To estimate the burden of invasive pneumococcal disease, non-bacteremic pneumococcal pneumonia, and acute otitis media before and after inclusion of the 13-valent pneumococcal vaccine (PCV13) into Taiwan\u2019s Childhood Immunization Program in 2015.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Episodes of eligible children aged\u2009&lt;\u200918 years hospitalized with invasive pneumococcal disease, non-bacteremic pneumococcal pneumonia, or acute otitis media between 1 January 2011 and 31 December 2019 were identified from the National Health Insurance Research Database. Annual hospitalized incidence rate, case fatality rate, and healthcare resource utilization and costs were estimated. Incidence time trends were assessed with interrupted time series analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>1,284 invasive pneumococcal disease episodes, 25,074 non-bacteremic pneumococcal pneumonia episodes, and 23,139 acute otitis media episodes were identified. The overall annual incidence rates of invasive pneumococcal disease, non-bacteremic pneumococcal pneumonia, and acute otitis media were 3.31, 64.61, and 59.62 episodes per 100,000 person-years, respectively. Interrupted time series analyses results showed a significantly lower baseline incidence rate (incidence rate ratio [IRR]:0.58, p-value\u2009=\u20090.001) for invasive pneumococcal disease, and significantly higher baseline incidence rate (IRR:1.17, p-value\u2009&lt;\u20090.001) for non-bacteremic pneumococcal pneumonia in the post-PCV13 period. Baseline incidence rates between the two periods were comparable for acute otitis media. A significant increase in trend of incidence rate was observed for all three diseases. Case fatality rate was 1.79%, 0.09%, and 0.00% for invasive pneumococcal disease, non-bacteremic pneumococcal pneumonia, and acute otitis media, respectively. Median length of hospitalization per inpatient visit was comparable between the two periods for invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia, but significantly shorter in the post-PCV13 period for acute otitis media. In the post-PCV13 period, average total costs per episode was lower for invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia, but higher for acute otitis media.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Residual clinical and economic burden of pneumococcal diseases remained substantial after PCV13 inclusion into Taiwan\u2019s Childhood Immunization Program. To further reduce the disease burden among children, additional research to investigate the cause of increasing trends of hospitalized invasive pneumococcal disease, non-bacteremic pneumococcal pneumonia and acute otitis media in the post-PCV13 era will be required.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-024-10379-z","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T13:11:37Z","timestamp":1738761097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015"],"prefix":"10.1186","volume":"25","author":[{"given":"Ting-An","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhong-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"See-Hwee","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dony","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy Thiow Koon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaya","family":"Sukarom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"issue":"7","key":"10379_CR1","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","volume":"6","author":"B Wahl","year":"2018","unstructured":"Wahl B, O\u2019Brien KL, Greenbaum A, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health. 2018;6(7):e744\u201357.","journal-title":"Lancet Glob Health"},{"issue":"8","key":"10379_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/cid\/ciu524","volume":"59","author":"ZB Harboe","year":"2014","unstructured":"Harboe ZB, Dalby T, Weinberger DM, et al. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis. 2014;59(8):1066\u201373.","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10379_CR3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa1401914","volume":"371","author":"A von Gottberg","year":"2014","unstructured":"von Gottberg A, de Gouveia L, Tempia S, et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014;371(20):1889\u201399.","journal-title":"N Engl J Med"},{"issue":"2","key":"10379_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.vaccine.2014.11.011","volume":"33","author":"A Lepoutre","year":"2015","unstructured":"Lepoutre A, Varon E, Georges S, et al. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001\u20132012. Vaccine. 2015;33(2):359\u201366.","journal-title":"Vaccine"},{"issue":"3","key":"10379_CR5","doi-asserted-by":"publisher","first-page":"e0120290","DOI":"10.1371\/journal.pone.0120290","volume":"10","author":"J Jokinen","year":"2015","unstructured":"Jokinen J, Rinta-Kokko H, Siira L, et al. Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children\u2013a population-based study. PLoS ONE. 2015;10(3):e0120290.","journal-title":"PLoS ONE"},{"issue":"49","key":"10379_CR6","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1016\/j.vaccine.2013.09.049","volume":"31","author":"W Rudnick","year":"2013","unstructured":"Rudnick W, Liu Z, Shigayeva A, et al. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995\u20132011. Vaccine. 2013;31(49):5863\u201371.","journal-title":"Vaccine"},{"issue":"3","key":"10379_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","volume":"15","author":"MR Moore","year":"2015","unstructured":"Moore MR, Link-Gelles R, Schaffner W, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15(3):301\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10379_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/cix850","volume":"66","author":"DL Luca","year":"2018","unstructured":"Luca DL, Kwong JC, Chu A, et al. Impact of pneumococcal vaccination on Pneumonia hospitalizations and related costs in Ontario: a Population-based ecological study. Clin Infect Dis. 2018;66(4):541\u20137.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10379_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.vaccine.2015.12.007","volume":"34","author":"S Sgambatti","year":"2016","unstructured":"Sgambatti S, Minamisava R, Bierrenbach AL, et al. Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance. Vaccine. 2016;34(5):663\u201370.","journal-title":"Vaccine"},{"issue":"43","key":"10379_CR10","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1016\/j.vaccine.2017.09.005","volume":"35","author":"C Alicino","year":"2017","unstructured":"Alicino C, Paganino C, Orsi A, et al. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: a systematic review and meta-analysis. Vaccine. 2017;35(43):5776\u201385.","journal-title":"Vaccine"},{"issue":"3","key":"10379_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1017\/S0950268815001272","volume":"144","author":"S Naito","year":"2016","unstructured":"Naito S, Tanaka J, Nagashima K, et al. The impact of heptavalent pneumococcal conjugate vaccine on the incidence of childhood community-acquired pneumonia and bacteriologically confirmed pneumococcal pneumonia in Japan. Epidemiol Infect. 2016;144(3):494\u2013506.","journal-title":"Epidemiol Infect"},{"issue":"39","key":"10379_CR12","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1016\/j.vaccine.2016.07.027","volume":"34","author":"V Suarez","year":"2016","unstructured":"Suarez V, Michel F, Toscano CM, et al. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses. Vaccine. 2016;34(39):4738\u201343.","journal-title":"Vaccine"},{"issue":"3","key":"10379_CR13","doi-asserted-by":"publisher","first-page":"e0172690","DOI":"10.1371\/journal.pone.0172690","volume":"12","author":"AA Palmu","year":"2017","unstructured":"Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Kilpi TM, Jokinen J. Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study. PLoS ONE. 2017;12(3):e0172690.","journal-title":"PLoS ONE"},{"issue":"4","key":"10379_CR14","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.anl.2017.10.006","volume":"45","author":"A Sasaki","year":"2018","unstructured":"Sasaki A, Kunimoto M, Takeno S, et al. Influence of pneumococcal conjugate vaccines on acute otitis media in Japan. Auris Nasus Larynx. 2018;45(4):718\u201321.","journal-title":"Auris Nasus Larynx"},{"issue":"11","key":"10379_CR15","first-page":"Cd001480","volume":"11","author":"JL de S\u00e9vaux","year":"2020","unstructured":"de S\u00e9vaux JL, Venekamp RP, Lutje V, et al. Pneumococcal conjugate vaccines for preventing acute otitis media in children. Cochrane Database Syst Rev. 2020;11(11):Cd001480.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10379_CR16","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/jac\/dkab167","volume":"76","author":"NK Vadlamudi","year":"2021","unstructured":"Vadlamudi NK, Saatchi A, Patrick DM, Rose C, Sadatsafavi M, Marra F. Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, Canada. J Antimicrob Chemother. 2021;76(9):2419\u201327.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10379_CR17","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1177\/147323000803600612","volume":"36","author":"F Ansaldi","year":"2008","unstructured":"Ansaldi F, Sticchi L, Durando P, et al. Decline in pneumonia and acute otitis media after the introduction of childhood pneumococcal vaccination in Liguria, Italy. J Int Med Res. 2008;36(6):1255\u201360.","journal-title":"J Int Med Res"},{"key":"10379_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpeds.2021.04.025","volume":"235","author":"T Marom","year":"2021","unstructured":"Marom T, Tshori S, Shefer G, Pitaro J. Pneumococcal conjugated vaccines decreased Acute Otitis Media Burden: a Population-based study in Israel. J Pediatr. 2021;235:233\u2013e83.","journal-title":"J Pediatr"},{"key":"10379_CR19","doi-asserted-by":"crossref","unstructured":"Barbieri E, Porcu G, Hu T et al. A retrospective database analysis to Estimate the Burden of Acute Otitis Media in Children aged\u2009<\u200915 years in the Veneto Region (Italy). Child (Basel). 2022;9(3).","DOI":"10.3390\/children9030436"},{"issue":"9","key":"10379_CR20","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/cid\/ciy1127","volume":"69","author":"CY Lu","year":"2019","unstructured":"Lu CY, Chiang CS, Chiu CH, et al. Successful control of Streptococcus pneumoniae 19A replacement with a catch-up primary vaccination program in Taiwan. Clin Infect Dis. 2019;69(9):1581\u20137.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10379_CR21","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1080\/21645515.2021.1985353","volume":"17","author":"QQ Du","year":"2021","unstructured":"Du QQ, Shi W, Yu D, Yao KH. Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines. Hum Vaccin Immunother. 2021;17(12):5628\u201337.","journal-title":"Hum Vaccin Immunother"},{"key":"10379_CR22","doi-asserted-by":"publisher","first-page":"557404","DOI":"10.3389\/fmicb.2020.557404","volume":"11","author":"CJ Wu","year":"2020","unstructured":"Wu CJ, Lai JF, Huang IW, Shiau YR, Wang HY, Lauderdale TL. Serotype distribution and Antimicrobial susceptibility of Streptococcus pneumoniae in pre- and Post- PCV7\/13 eras, Taiwan, 2002\u20132018. Front Microbiol. 2020;11:557404.","journal-title":"Front Microbiol"},{"issue":"2","key":"10379_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7774\/cevr.2015.4.2.121","volume":"4","author":"SH Wei","year":"2015","unstructured":"Wei SH, Chiang CS, Chen CL, Chiu CH. Pneumococcal disease and use of pneumococcal vaccines in Taiwan. Clin Exp Vaccine Res. 2015;4(2):121\u20139.","journal-title":"Clin Exp Vaccine Res"},{"issue":"3","key":"10379_CR24","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1097\/INF.0000000000000565","volume":"34","author":"SH Wei","year":"2015","unstructured":"Wei SH, Chiang CS, Chiu CH, Chou P, Lin TY. Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2015;34(3):e71\u20137.","journal-title":"Pediatr Infect Dis J"},{"key":"10379_CR25","doi-asserted-by":"crossref","unstructured":"Shen CF, Chen JL, Su CC et al. Decrease of Pneumococcal Community-Acquired Pneumonia hospitalization and Associated complications in children after the implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan. Vaccines (Basel). 2021;9(9).","DOI":"10.3390\/vaccines9091043"},{"issue":"9","key":"10379_CR26","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1001\/jamainternmed.2015.3540","volume":"175","author":"AW Hsing","year":"2015","unstructured":"Hsing AW, Ioannidis JP. Nationwide Population Science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015;175(9):1527\u20139.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10379_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12916-018-1004-z","volume":"16","author":"D Thorrington","year":"2018","unstructured":"Thorrington D, Andrews N, Stowe J, Miller E, van Hoek AJ. Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control. BMC Med. 2018;16(1):13.","journal-title":"BMC Med"},{"key":"10379_CR28","unstructured":"JE C. Chapter 11 - Otolaryngology. In: An Osteopathic Approach to Children: Edinburgh: Churchill Livingstone. 2009. Available at: https:\/\/www.elsevier.com\/books\/an-osteopathic-approach-to-children\/9780443067389. Accessed 7 November 2022."},{"issue":"1","key":"10379_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jamapediatrics.2013.3924","volume":"168","author":"T Marom","year":"2014","unstructured":"Marom T, Tan A, Wilkinson GS, Pierson KS, Freeman JL, Chonmaitree T. Trends in otitis media-related health care use in the United States, 2001\u20132011. JAMA Pediatr. 2014;168(1):68\u201375.","journal-title":"JAMA Pediatr"},{"key":"10379_CR30","unstructured":"National Institute of Health Technology Assessment N. HTA guidelines [Available from: https:\/\/nihta.cde.org.tw\/Service\/Rule?id=3"},{"issue":"4","key":"10379_CR31","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1097\/INF.0000000000001054","volume":"35","author":"WJ Su","year":"2016","unstructured":"Su WJ, Lo HY, Chang CH, et al. Effectiveness of Pneumococcal Conjugate vaccines of different valences against Invasive Pneumococcal Disease among children in Taiwan: a Nationwide Study. Pediatr Infect Dis J. 2016;35(4):e124\u201333.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10379_CR32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1099\/jmm.0.000488","volume":"66","author":"RP Janapatla","year":"2017","unstructured":"Janapatla RP, Su LH, Chen HH, et al. Epidemiology of culture-confirmed infections of Streptococcus pneumoniae (2012\u20132015) and nasopharyngeal carriage in children and households in Taiwan (2014\u20132015). J Med Microbiol. 2017;66(6):729\u201336.","journal-title":"J Med Microbiol"},{"issue":"6","key":"10379_CR33","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jinf.2022.04.022","volume":"84","author":"CH Chen","year":"2022","unstructured":"Chen CH, Janapatla RP, Su LH, et al. Incidence rates, emerging serotypes and genotypes, and antimicrobial susceptibility of pneumococcal disease in Taiwan: a multi-center clinical microbiological study after PCV13 implementation. J Infect. 2022;84(6):788\u201394.","journal-title":"J Infect"},{"issue":"2","key":"10379_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1586\/eri.09.112","volume":"8","author":"E Leibovitz","year":"2010","unstructured":"Leibovitz E, Broides A, Greenberg D, Newman N. Current management of pediatric acute otitis media. Expert Rev Anti Infect Ther. 2010;8(2):151\u201361.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10379_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jmii.2017.08.020","volume":"52","author":"YC Cho","year":"2019","unstructured":"Cho YC, Chiu NC, Huang FY, et al. Epidemiology and antimicrobial susceptibility of non-typeable Haemophilus influenzae in otitis media in Taiwanese children. J Microbiol Immunol Infect. 2019;52(1):75\u201380.","journal-title":"J Microbiol Immunol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10379-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10379-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10379-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T13:11:43Z","timestamp":1738761103000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10379-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10379"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10379-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"24 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the institutional review board of National Taiwan University Hospital (REC no. 202012193RFIC). Informed consent was waived because of the study\u2019s descriptive and non-interventional nature, and the analysis was de-identified. This study was conducted in accordance with the Declaration of Helsinki and local guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TAY, JLW, LYH have no competing interests to report. CCW received a research grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. SHY, DP, CTKL, and HWL are employees of IQVIA and were paid consultants to Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA in connection with this study. IS and EY are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and shareholders in Merck & Co., Inc., Rahway, NJ, USA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}